Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Heise

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Hepatology (Baltimore, Md.)|January 22, 2017
Activation of silent mating type information regulation 2 homolog 1 by human chorionic gonadotropin exerts a therapeutic effect on hepatic injury and inflammationCaroline Steinmetz, Anubha Kashyap, Nataliya Zhivkova, et al.
Transplantation Direct|July 15, 2017
Liver Preservation by Aortic Perfusion Alone Compared With Preservation by Aortic Perfusion and Additional Arterial Ex Situ Back-Table Perfusion With Histidine-Tryptophan-Ketoglutarate Solution: A Prospective, Randomized, Controlled, Multicenter StudyGerd Otto, Michael Heise, Jochen Thies, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|January 15, 2020
[Introduction of an interdisciplinary tumor board leads to improvement of treatment outcome of cholangiocarcinoma (bile duct cancer)]Mazen A Juratli, Konstantin Hofmann, Ümniye Balaban, et al.
Transplantation|February 7, 2018
Extended Pancreas Donor Program-The EXPAND Study: A Prospective Multicenter Trial Testing the Use of Pancreas Donors Older Than 50 YearsAndrea Proneth, Andreas A Schnitzbauer, Peter Schenker, et al.
European Journal of Internal Medicine|June 4, 2018
Recipient liver function before liver transplantation influences post-transplantation survival in patients with HCCFriedrich Foerster, Jens Mittler, Felix Darstein, et al.
Transplantation Research|July 3, 2013
Extended pancreas donor program - the EXPAND study rationale and study protocolAndrea Proneth, Andreas A Schnitzbauer, Florian Zeman, et al.
Clinical and Translational Medicine|June 15, 2024
Integrative genomic analyses of European intrahepatic cholangiocarcinoma: Novel ROS1 fusion gene and PBX1 as prognostic markerPatrick S Plum, Timo Hess, Denis Bertrand, et al.
Annals of Surgery|September 5, 2020
mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active TumorsAndreas A Schnitzbauer, Natalie Filmann, René Adam, et al.
BMC Cancer|May 13, 2010
A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinomaAndreas A Schnitzbauer, Carl Zuelke, Christian Graeb, et al.
Transplantation|November 12, 2015
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 TrialEdward K Geissler, Andreas A Schnitzbauer, Carl Zülke, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Hepatology (Baltimore, Md.)|January 22, 2017
Activation of silent mating type information regulation 2 homolog 1 by human chorionic gonadotropin exerts a therapeutic effect on hepatic injury and inflammationCaroline Steinmetz, Anubha Kashyap, Nataliya Zhivkova, et al.
Transplantation Direct|July 15, 2017
Liver Preservation by Aortic Perfusion Alone Compared With Preservation by Aortic Perfusion and Additional Arterial Ex Situ Back-Table Perfusion With Histidine-Tryptophan-Ketoglutarate Solution: A Prospective, Randomized, Controlled, Multicenter StudyGerd Otto, Michael Heise, Jochen Thies, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|January 15, 2020
[Introduction of an interdisciplinary tumor board leads to improvement of treatment outcome of cholangiocarcinoma (bile duct cancer)]Mazen A Juratli, Konstantin Hofmann, Ümniye Balaban, et al.
Transplantation|February 7, 2018
Extended Pancreas Donor Program-The EXPAND Study: A Prospective Multicenter Trial Testing the Use of Pancreas Donors Older Than 50 YearsAndrea Proneth, Andreas A Schnitzbauer, Peter Schenker, et al.
European Journal of Internal Medicine|June 4, 2018
Recipient liver function before liver transplantation influences post-transplantation survival in patients with HCCFriedrich Foerster, Jens Mittler, Felix Darstein, et al.
Transplantation Research|July 3, 2013
Extended pancreas donor program - the EXPAND study rationale and study protocolAndrea Proneth, Andreas A Schnitzbauer, Florian Zeman, et al.
Clinical and Translational Medicine|June 15, 2024
Integrative genomic analyses of European intrahepatic cholangiocarcinoma: Novel ROS1 fusion gene and PBX1 as prognostic markerPatrick S Plum, Timo Hess, Denis Bertrand, et al.
Annals of Surgery|September 5, 2020
mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active TumorsAndreas A Schnitzbauer, Natalie Filmann, René Adam, et al.
BMC Cancer|May 13, 2010
A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinomaAndreas A Schnitzbauer, Carl Zuelke, Christian Graeb, et al.
Transplantation|November 12, 2015
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 TrialEdward K Geissler, Andreas A Schnitzbauer, Carl Zülke, et al.
Pageof 8